To hear about similar clinical trials, please enter your email below
Trial Title:
Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma
NCT ID:
NCT06243588
Condition:
Ewing Sarcoma
Conditions: Official terms:
Sarcoma
Sarcoma, Ewing
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Other
Intervention name:
clinical records review
Description:
review the medical records, radiological imaging, and histological data of these patients
Arm group label:
Patients
Summary:
assess whether there is a correlation between some factors (age, sex, tumor volume, tumor
site, chemotherapy-induced necrosis, radiation and biomarkers) and overall survival (OS)
and relapse-free survival (RFS) in patients with Ewing sarcoma.
Identification of reliable prognostic factors could help to identify high-risk patients,
which may require a different treatment and follow up.
Criteria for eligibility:
Study pop:
Male and female patients treated at Rizzoli Orthopaedic Institute between 01/01/1991 and
31/12/2021
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Male and female patients treated at Rizzoli Orthopaedic Institute between 01/01/1991
and 31/12/2021
- Age ≥ 2 years
- Diagnosis of Ewing Sarcoma
- Patients with available clinical and imaging data
Exclusion Criteria:
- At least one inclusion criterion not met
Gender:
All
Minimum age:
2 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
IRCCS Itituto Ortopedico Rizzoli
Address:
City:
Bologna
Zip:
40136
Country:
Italy
Status:
Recruiting
Contact:
Last name:
Costantino Errani, MD
Start date:
January 25, 2024
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Istituto Ortopedico Rizzoli
Agency class:
Other
Source:
Istituto Ortopedico Rizzoli
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06243588
